Regulatory Reform

Regulatory Reform and Policy Initiatives for OTPs in a Post COVID-19 World

Introduction
The Combined COVID-19 Pandemic and Opioid Use
Brief Historical Background
The Impact of COVID-19 on OTPs
Expanding the Footprint of OTPs in United States
Funding
Mobile Vans
Satellite Medication Units
Telehealth Services Through OTPs
Increased Access to Interim Care through an OTP
Dispensing of Methadone Through Pharmacies
Recommended Changes in Federal and State Oversight for OTPs
Moving Forward with Innovative Change
Workforce Shortages and Development
Recommendations
References

As supporters of #MedicationAssistedTreatment, we understand the dangers of allowing methadone – a Schedule II narcotic – to be distributed at local pharmacies. 
 
ACT NOW by telling Congress to protect the #OTP standard of care & our communities: https://programnotapill.com/write-congress/ #PNAP

Load More...

#aatod2022 conference


AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram

Stay Connected to AATOD